Abbott Laboratories (NYSE:ABT) Q3 2025 Earnings Call October 15, 2025 9:00 AM EDT
Company Participants
Michael Comilla – Vice President of Investor Relations.
Robert Ford – Chairman of the Board, President & CEO
Philip Boudreau – CFO & Executive VP of Finance
Conference Call Participants
Larry Biegelsen – Wells Fargo Securities, LLC, Research Division
Robert Marcus – JPMorgan Chase & Co, Research Division
David Roman – Goldman Sachs Group, Inc., Research Division
Joshua Jennings – TD Cowen, Research Division
Vijay Kumar – Evercore ISI Institutional Equities, Research Division
Danielle Antalffy – UBS Investment Bank, Research Division
Joanne Wuensch – Citigroup Inc., Research Division
Travis Steed – BofA Securities, Research Division
Suraj Kalia – Oppenheimer & Co. Inc., Research Division
Presentation
Operator
Good morning, and thank you for standing by. Welcome to Abbott’s Third Quarter 2025 Earnings Conference Call. [Operator Instructions] This call is being recorded by Abbott. With the exception of any participant’s questions asked during the question-and-answer session, the entire call, including the question-and-answer session, is material copyrighted by Abbott. It cannot be recorded or rebroadcast without Abbott’s expressed written permission. I would now like to introduce Mr. Mike Comilla, Vice President, Investor Relations.
Michael Comilla
Vice President of Investor Relations.
Good morning, and thank you for joining us. With me today are Robert Ford, Chairman and Chief Executive Officer; and Phil Boudreau, Executive Vice President, Finance and Chief Financial Officer. Robert and Phil will provide opening remarks. Following their comments, we’ll take your questions. Before we get started, some statements made today may be forward-looking for purposes of the Private Securities Litigation Reform Act of 1995, including the expected financial results for 2025.
Abbott cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Economic, competitive, governmental, technological, and other factors that may affect Abbott’s
Read the full article here
